Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
8 studies found for:    "Myelomeningocele"
Show Display Options
RSS Create an RSS feed from your search for:
"Myelomeningocele"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Effect of Botulinum Toxin in Neurogenic Bladders in Children With Myelomeningocele
Conditions: Myelomeningocele;   Bladder, Neurogenic
Intervention: Drug: Botulinum A toxin
2 Recruiting Prenatal Surgical Repair of Fetal Myelomeningocele
Condition: Foetus With Myelomeningocele
Intervention: Procedure: prenatal surgical repair of fetal myelomeningocele
3 Active, not recruiting Management of Myelomeningocele Study (MOMS)
Conditions: Meningomyelocele;   Spinal Dysraphism
Interventions: Procedure: Prenatal Myelomeningocele Repair Surgery;   Procedure: Postnatal Myelomeningocele Repair Surgery
4 Active, not recruiting Brain Function and White Matter Changes in Congenital, Acute and Chronic Spinal Cord Lesions
Conditions: Paraplegia, Spinal;   Myelomeningocele
Intervention: Other: fMRI, DTI
5 Recruiting Reciprocating Gait Orthoses for Paraplegia Patients
Conditions: Myelomeningocele;   Spinal Cord Injury;   Spinal Muscular Atrophy
Intervention: Device: RGOs(reciprocating gait orthoses)
6 Recruiting Fetoscopic Meningomyelocele Repair Study
Condition: Neural Tube Defect Repair
Intervention: Procedure: fetoscopy
7 Enrolling by invitation Bacteriuria Eradication Through Probiotics
Condition: Bacteriuria
Intervention: Dietary Supplement: Lactobacillus reuteri RC-14 and Lactobacillus rhamnosus GR-1
8 Terminated 2 Week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Yrs) With Neurogenic Detrusor Overactivity
Condition: Neurogenic Detrusor Overactivity
Intervention: Drug: Darifenacin

Indicates status has not been verified in more than two years